Navigation Links
A Slow Economy and High Development Costs to Drive Rise in Pharmaceutical Outsourcing to Contract Research Organizations
Date:8/22/2012

FARMINGTON, Conn., Aug. 22, 2012 /PRNewswire-iReach/ -- It's a well known data point that while the pills a doctor prescribes may cost pennies each to manufacture, the first pill cost many millions of dollars to research, develop, test, and certify. Along the way, many routes are pursued and ultimately dropped when they fail to yield marketable results. One way drug manufacturers can lower their costs and increase their output is to outsource stages of the process to Contract Research Organizations (CROs) that specialize in drug discovery, hit confirmation, and lead optimization.

(Photo: http://photos.prnewswire.com/prnh/20120822/CG61248)

Global Information Inc, in cooperation with its premium market research publishing partners, is pleased to announce three new market research reports exploring the market for CROs, providing valuable data for market participants – both CROs and pharmaceutical companies themselves – as well as investors, reporters, analysts, and regulators.

Contract Research Organization Market in the US 2011-2015

TechNavio's analysts forecast the Pharmaceutical Contract Research Organization market in the US will grow at a CAGR of 9.7 percent between 2011 and 2015. One of the key factors contributing to this is the increasing outsourcing of R&D activities. The CRO market in the US has also been witnessing the trend of emerging outsourcing destinations. However, the shortage of CRO staff could pose a challenge to the growth of this market.

TechNavio's report, The Contract Research Organization Market in the US 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the USA region; it also covers the Contract Research Organization market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include Charles River Laboratories International Inc., Covance Inc., Pharmaceutical Product Development Inc., Quintiles Transnational Corp.

An Executive Summary, table of contents, and free sample are available from GII at http://www.giiresearch.com/report/infi248653-contract-research-organization-market-us.html

Medical Devices Contract Research Organizations - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018

GlobalData's new market research report, Medical Devices Contract Research Organizations - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018, provides key data, information and analysis on the global medical devices CRO market. This report outlines the current market and competitive landscapes, gives market trend information for the medical devices CRO market, and provides comprehensive information on the key trends affecting the market, as well as key analytical content. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

An Executive Summary of this analysis, full table of contents, and a free sample of the full report are available at http://www.giiresearch.com/report/gd244312-medical-devices-contract-research-organizations.html

Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market

The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a target protein or nucleic acid in a way that is useful for treatment of disease. The process by which molecules are identified for their therapeutic value involves synthesis and analysis of many derivatives of the original leads. There are several steps in the drug discovery process including hit confirmation, lead generation, lead optimization, and other studies. Drug discovery is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will actually yield products that achieve regulatory approval by the Food & Drug Administration (FDA).

Since the last edition of Kalorama's Report on the outsourcing of discovery of novel compounds in the pharmaceutical industry, the industry has seen dramatic change. Pharmaceutical companies facing cutbacks in R&D budgets and new demands for novel products need to outsource aspects of their operations. Core functions once kept in-house such as the discovery of potential new drugs are now commonly outsourced. Kalorama Information's Outsourcing in Drug Discovery captures this trend, offering unparalleled coverage of the drug discovery outsourcing market. It presents viewpoints from both customers and suppliers. Segments, size, and growth of the market are presented. The trend toward the increased use of offshore suppliers in China, India, Russia and Eastern Europe is covered in detail. The report also provides profiles of 23 suppliers, representative of those active in this market.

An Executive Summary of this analysis and a free sample of the full report are available at http://www.giiresearch.com/report/kl241549-outsourcing-drug-discovery-contract-research.html

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia, Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. NationsHealth, Inc. Boosts Arizona Economy With Business Expansion
2. Telemedicine, Teleradiology, and Telemonitoring Look Like Winners in the New Healthcare Economy
3. New Report Shows Ohio Clinical Trials Benefit Patients, the Economy and Science
4. AdvaMed & BioOhio Discuss MedTech Impact on Ohios Economy, Job Creation
5. Epigenomics Presents Significant Opportunities for Investment and Product Development, According to New Biotech Market Research
6. Nectid Announces Initiation Of Clinical Development Of Autism And Pain Drugs
7. Regulus Therapeutics Forms Strategic Alliance for Discovery, Development and Commercialization of microRNA Therapeutics with AstraZeneca
8. Fetal Surveillance Company, PeriGen, Inc., to Collaborate with National Institute of Child Health and Human Development to Research Fetal Heart Rate Patterns During Labor
9. Cardium Presents Second Quarter 2012 Financial Results And Reports On Recent Developments
10. Major Breakthrough in Hepatitis C Vaccine Development
11. Elcelyx Therapeutics Names Mark Wiggins Senior Vice President of Business Development, Ginger Graham to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... KALAMAZOO, Mich. , Sept. 18, 2017 /PRNewswire/ ... and OptiMed Specialty Pharmacy of Kalamazoo, Mich. ... a strategic hub service that expedites and streamlines patient ... spirometer, Spiro PD 2.0, and wellness management services.  ... a medical device used to measure lung function for ...
(Date:9/13/2017)... has been named the official orthopedic and sports medicine ... 2018 College Football Playoff (CFP) National Championship to be played ... Atlanta, Georgia . OrthoAtlanta is proud to be ... many activities leading up to, and including the national championship ... OrthoAtlanta serves ...
(Date:9/12/2017)...  Consumer reviews on the independent review site Consumer Affairs ... company for hearing aids, ranking it higher than Miracle Ear ... ... For Hearing Aids ... online store that provides high performance, state-of-the-art, German-engineered hearing aids directly ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of ... its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his ... July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming ...
(Date:10/13/2017)... ... 13, 2017 , ... Apple Rehab Shelton Lakes , which specializes in ... the facility as part of a disaster drill on October 3rd. , Apple Rehab ... City Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
Breaking Medicine News(10 mins):